TD Asset Management »

Mbx Biosciences shares owned by TD Asset Management

Quarter-by-quarter ownership of Mbx Biosciences shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 45k 23.95

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Canadian Pacific Kansas City (CP)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Broadcom (AVGO)
Canadian Natural Resources (CNQ)
Cibc Cad (CM)
UnitedHealth (UNH)

View all positions for TD Asset Management

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
OrbiMed Advisors
NEA Management Company
NVP Associates
RA Capital Management
T. Rowe Price Associates
Driehaus Capital Management
Woodline Partners
Franklin Resources
Alyeska Investment Group
Platinum Investment Mangement
Citadel Advisors
Stempoint Capital
Monashee Investment Management
TD Asset Management

View all funds holding Mbx Biosciences